Bamboo Therapeutics Overview
- Founded
-
2014

- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$645M
Bamboo Therapeutics General Information
Description
Developer of gene therapies for the treatment of monogenic disorders. The company specializes in developing therapeutic reagents to diagnose diseases related to central nervous system and neuromuscular conditions.
Contact Information
Website
www.bambootherapeutics.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Therapeutic Devices
Acquirer
Primary Office
- 870 Martin Luther King Jr Boulevard
- Chapel Hill, NC 27514
- United States
Bamboo Therapeutics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Merger/Acquisition | 01-Aug-2016 | $645M | 000.00 | 00000 | Completed | Startup |
1. Early Stage VC | 11-Feb-2016 | 000.00 | 000.00 | Completed | Startup |
Bamboo Therapeutics Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Developer of gene therapies for the treatment of monogenic disorders. The company specializes in developing therapeutic
Biotechnology
Chapel Hill, NC
000.00
0000
0000-00-00
000000&0
000.00
Bamboo Therapeutics Competitors (27)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Regenxbio | Formerly VC-backed | Rockville, MD | 000 | 00000 | 000000000 | 00000 |
000000 0000000000 | Formerly VC-backed | Vancouver, Canada | 00 | 000.00 | 00000000 | 000.00 |
00000000 000000000 | Formerly VC-backed | Cambridge, MA | 000 | 00000 | 000000 - 000 | 00000 |
000000000 | Corporation | Melbourne, Australia | 00 | 00000 | 000000000 | 00000 |
0000000 0000000 00 | Corporation | Alachua, FL | 000 | 00000 | 000000000000 | 00000 |
Bamboo Therapeutics Patents
Bamboo Therapeutics Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2017281983-B2 | Optimized mini-dystrophin genes and expression cassettes and their use | Active | 21-Jun-2016 | 00000000000 | 0 |
AU-2017281983-A1 | Optimized mini-dystrophin genes and expression cassettes and their use | Active | 21-Jun-2016 | 00000000000 | |
JP-6793758-B2 | Optimized mini-dystrophin genes and expression cassettes and their use | Active | 21-Jun-2016 | 00000000000 | |
JP-2021045136-A | Optimized mini-dystrophin gene and expression cassette and their use | Active | 21-Jun-2016 | 00000000000 | 0 |
US-20170368198-A1 | Optimized mini-dystrophin genes and expression cassettes and their use | Inactive | 21-Jun-2016 | A61K38/1709 |
Bamboo Therapeutics Executive Team (11)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Xiao Xiao Ph.D | Co-Founder |
Bamboo Therapeutics Former Investors (1)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
CureDuchenne Ventures | Corporate Venture Capital | Minority | 000 0000 | 000000 0 |
Bamboo Therapeutics Investments (1)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
0000000000 00 | 08-Jan-2016 | 000000000 | Buildings and Property | 0000000 0 |